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Summary In the family reported here, a mother and both of her children developed a Wilms tumour, and all
three tumours were of the relatively rare monomorphous epithelial histopathological subtype. Using restriction
fragment length polymorphism analysis, both sibs were shown to inherit the same maternal allele from the
llpl3 region but different maternal alleles from the lIplS region. Using a combination of single-strand
conformation polymorphism (SSCP) and polymerase chain reaction (PCR) sequencing techniques, no muta-
tions were identified in the WTI tumour-suppressor gene from the 1lp13 region, but a novel polymorphism
was identified in exon 1. mRNA expression studies using the insulin-like growth factor II (IGF-II) gene,
located in 11 p15, showed that there was no relaxation of imprinting at this locus. There was also no evidence
of loss of heterozygosity on the long arm of chromosome 16. These findings indicate that the WTI and IGF-II
genes, together with the long arm of chromosome 16, are not directly implicated in tumorigenesis in this
Wilms family, but that a recombination event has occurred on the short arm of chromosome 11.
Patients with Wilms tumour (WT) and the so-called 'AGR
triad' (aniridia, genitourinary abnormalities and mental
retardation) invariably carry constitutional deletions involv-
ing the lipl3 region (Francke et al., 1979; Riccardi et al.,
1978, 1980). Studies of polymorphic loci along the length
of the short arm ofchromosome 11 have revealed that loss of
heterozygosity (LOH) from I lp also occurs in up to 30% of
sporadic WTs (Fearon et al., 1984; Koufos et al., 1984; Orkin
et al., 1984; Mannens et al., 1988; Wadey et al., 1990). In
some cases, however, LOH is found only in region 11 p15 and
not in lipl3 (Mannens et al., 1988, 1990; Reeve et al., 1989;
Wadey et al., 1990). These findings support the idea that
genes in both the p13 and p15 regions of chromosome 11 are
important in Wilms tumorigenesis.
Analysis of a number of deletions from WAGR patients
defined the critical region of lp13, which led to the isolation
of a candidate gene from this region (Call et al., 1990;
Gessler et al., 1990), known as WTI (Haber et al., 1990).
WTI consists of 10 exons, the last four of which each codes
individually for a zinc finger (Haber et al., 1990). The
demonstration of a number of intragenic WTI deletions in
tumour cells has provided evidence for a direct role for WTI
in tumorigenesis (Haber et al., 1990; Cowell et al., 1991; Huff
et al., 1991; Ton et al., 1991; Brown et al., 1992). Recently,
more precise analysis has led to identification of more subtle
changes in WTI, including point mutations (Pelletier et al.,
1991; Baird et al., 1992a,b; Coppes et al., 1992; Little et al.,
1992) and insertions (Baird et al., 1992a; Santos et al., 1993)
from patients with both WAGR syndrome and sporadic
unilateral and bilateral WT. This gene is therefore implicated
directly in Wilms tumorigenesis, at least in some patients.
Beckwith-Wiedemann syndrome (BWS) is an overgrowth
syndrome that is also associated with tumour predisposition,
but only 6% of patients develop WTs (Beckwith, 1963;
Wiedemann, 1964). Genetic analysis of BWS families has
demonstrated linkage to markers on the short arm of
chromosome 11 (Koufos et al., 1989; Ping et al., 1989). This
observation indicates the location of the BWS gene, which
might also be involved in Wilms tumorigenesis, as suggested
by LOH studies. Cytogenetic changes involving the Ilpl5
region (Waziri et al., 1983; Turleau et al., 1984) in a few
BWS patients provides supportive evidence, although a
specific candidate gene has not yet been identified.
LOH is generally considered to be a mechanism that
'exposes' recessive mutations in tumour-suppressor genes
(Cavenee et al., 1983). Recent LOH analysis of various
chromosomal loci, other than llp, has demonstrated allele
loss from the long arm of chromosome 16 in up to 20% of
sporadic WTs (Maw et al., 1992). Because these changes also
occur in tumours showing LOH for llp, it has been sug-
gested they are related to progression rather than initiation.
Examples of pedigrees segregating a predisposition to
Wilms tumorigenesis are quite rare, with estimates of fewer
than 1% of all reported patients having affected sibs or
parents. Linkage analysis in four families with apparently
dominant inheritance of WT, but with varying penetrance,
has excluded the short arm of chromosome 11 (Grundy et
al., 1988; Huff et al., 1988; Schwartz et al., 1991) and 16q
(Huff et al., 1992) as the site of the hereditary predisposition
gene in these patients. Clearly, the molecular pathogenesis of
familial WT varies, and characterisation of other WT
families is needed. We report here the analysis of a British
WT family using markers from the short arm ofchromosome
11 and the long arm of chromosome 16.
Family history
The family (family M) reported here represents the only
two-generation family with Wilms tumour amongst the 983
cases currently notified to the UKCCSG Wilms tumour trials
since their inception in 1979 (see Figure 1 for pedigree).
The mother (GOS 570) had a unilateral renal tumour
diagnosed at the age of 6 months, which was resected: she
received post-operative flank irradiation but no chemo-
therapy. She is now aged 25 years and remains healthy. Each
of her children (GOS 250 and GOS 416) presented with
unilateral, unifocal tumours, the boy at age 8 months and the
girl at age 5 months. A maternal great uncle developed
adenocarcinomatosis at age 56 (the primary tumour was
thought to be in the colon or pancreas) but no other family
member had a history of cancer or renal tumour. Patient
GOS 250 was treated with surgery and ten injections of
vincristine but no radiotherapy, and patient GOS 416 with
surgery alone. Both children are probably cured: GOS 250 is
51 months and GOS 416 is 42 months off treatment, without
evidence of tumour recurrence.
Remarkably, all three tumours were of the monomorphic
epithelial 'favourable histology' subtype. In addition, each
patient was diagnosed at a very young age, compared with
the 36 month average seen in sporadic WT. Although only a
single tumour developed in each case, these features are
strongly suggestive of a predisposition.
Tissue samples
Fresh tumour samples were snap frozen in liquid nitrogen
soon after the time of surgical resection. Epstein-Barr virus
(EBV)-transformed lymphoblastoid cell lines were prepared
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Figure 1 Four-generation pedigree offamily M. Members of this
family affected with unilateral WT are indicated (EJ, 0) M
represents the patient with adenocarcinomatosis.
from freshly isolated lymphocytes and used to make constitu-
tional DNA. The constitutional karyotype of family members
was determined by standard methods of G-banding from
peripheral blood lymphocytes.
Genomic DNA isolation
High molecular weight DNA from tumour samples was
prepared by grinding tissue to a fine powder in liquid nitro-
gen and resuspending it in approximately 20 ml of lysis buffer
(50 mM sodium chloride, 10 mM EDTA, 150 mM Tris, 0.5%
SDS). Proteolysis was achieved using 50 mgml-' proteinase
K for 16-24 h at 37°C. DNA was extracted using standard
phenol-chloroform procedures (Sambrook et al., 1989).
EBV-transformed lymphoblastoid cell lines were resuspended
in lysis buffer and DNA extracted in the same way.
RNA isolation and reverse transcription-polymerase chain
reaction (RT-PCR)
Total cellular RNA was isolated from tumour samples
using the acid guanidinium thiocyanate-phenol-chloroform
method described by Chomczynski and Sacchi (1988).
RT-PCR was essentially as described by Baird et al. (1992a),
except that 30 instead of 40 cycles of PCR amplification were
carried out.
DNA analysis
LOH analysis of polymorphic markers from chromosome 11
was performed as previously described (Wadey et al., 1990).
Genomic DNA was amplified using a Techne PHC-2 ther-
mocycler. The PCR, single-strand conformation polymor-
phism (SSCP) and direct sequencing procedures were
essentially as described by Hogg et al. (1992), using a series
of oligonucleotide primers described previously (Baird et al.,
1992a). The WTJ oligonucleotide primers used widely in this
study are those which amplify the 3' end of exon 1 of the
gene and are designated:
WTCIA 5'-TTCACTGTCCACTTTTCCGGCCAGT-3'
WT3 x 1 5'-TAGGGGCGCTCCCCGGCCTA-3'
WTC1A is a 25mer sense primer, starting at nucleotide posi-
tion 274 of the sequence described by Haber et al. (1991),
whereas WT3 x 1 is a 20mer antisense biotinylated primer,
starting 26 bp 3' to the end of exon 1. Additional primer
pairs used for LOH analysis were derived for D16S289 for
chromosome region 16q22.2-q23.1 (Shen et al., 1992) and
D16S305 for chromosome region 16q24.2-q24.3 (Thomson
et at., 1992). These two sets of primers were used to amplify
CA repeats. All primers were synthesised on phosphoramide
columns (ICRF Central Services Division). Amplified pro-
ducts, except CA repeats, were electrophoresed on 2%
agarose gels. In the case of CA repeats, SSCP-PCR reac-
tions involving 30 cycles ofPCR were performed as described
by Hogg et al. (1992) and the products electrophoresed on
6% polyacrylamide-urea gels.
Expression studies
Primers P2 and P3, previously described by Ogawa et al.
(1993), were used to amplify part of the 3' untranslated
region of the IGF-II gene using PCR (Ogawa et al., 1993;
Rainer et al., 1993) and conditions of 50°C for 30 s, 72°C for
30 s and 96°C for 30s for 30 cycles from first-strand syn-
thesised cDNA (Baird et al., 1992a). Subsequent ApaI diges-
tion of the resulting 292 bp PCR product allowed
identification of both alleles associated with this polymor-
phism (Tadokaro et al., 1992). RNA preparations were
treated with RNAse-free DNAse prior to PCR amplification.
Results
Cytogenetic analysis of constitutional cells from all four
family members showed normal karyotypes. Therefore PCR
was used to analyse constitutional DNA from all three
affected members as well as tumour tissue (GOS 249 and
GOS 399 respectively) from both GOS 250 and GOS 416.
Initially the polymorphic HindIII site within the P-globin
gene (HBG) locus, which lies in lp15, was studied. If this
site was present, the 328 bp fragment generated by the
primers A 11/A12 (Baird et al., 1992a) was digested, resulting
in two bands 91 bp and 237 bp long (Figure 2). The affected
mother (GOS 570) was heterozygous at this locus. The
unaffected father (GOS 571) and his son (GOS 250) were
homozygous for the 328 bp band, but the daughter (GOS
416) was heterozygous (Figure 2). This observation indicated
that the two children had inherited different copies of
chromosome 11 from their mother. Analysis of the HRAS
locus, which is located more distally in llpl5, using the
EcoRI polymorphism (Feinberg & Vogelstein, 1983),
confirmed that both sibs had inherited different alleles from
their mother (Figure 3) and excluded the possibility that the
'predisposing gene' lay in this region.
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Figure 2 Analysis of the polymorphic HindJII P-globin gene
locus in family M. When the normal 328 bp PCR products are
digested with HindIII, two bands, 237 bp and 91 bp long, are
produced. One kilobase ladder markers were loaded in lanes 1
and 8. The polymorphic variant destroys the HindIII site. PCR
products from blood DNA show that the affected mother (M) is
heterozygous and the unaffected father (F) is homozygous for the
upper allele (lanes 2 ad 3 respectively). Lanes 4-7 represent DNA
products from normal (N) or tumour (T) cells from the two
affected probands (GOS 250 and GOS 416). GOS 250 and GOS
416 have inherited different maternal alleles.1074 P.N. BAIRD et al.
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Figure 3 Summary of maternal haplotypes for the llpl3-llpl5 region in patients from family M with WT. The mother was
heterozygous at those loci indicated and homozygous for the others. In GOS 416 a recombination event has occurred between the
WTI and p56H loci. AN indicates the position of the heredity aniridia gene.
Analysis of the catalase (CAT) locus, however, which lies
proximal to the WTI gene in lp13, showed that both
children had inherited the same allele from their mother
(Figure 3). Clearly, a recombination event had occurred
between the p13 and p15 region on the short arm of
chromosome 11. Using a number of other lip probes the
recombination event was shown to have occurred between
the CAT and FSHB loci in lpl3 (Figure 3). It was still not
clear, however, whether this had occurred distal to, or prox-
imal to, the WTI gene. To resolve this issue we analysed the
WTI gene directly. Previous Southern blot analysis of the
1ipi3 region had shown no obvious LOH in tumours
derived from either GOS 250 or GOS 416 (Wadey et al.,
1990) and experiments with the WT33 cDNA probe (Call et
al., 1990) showed no gross structural rearrangements in the
WTI gene (Cowell et al., 1991). Analysis of known polymor-
phisms in exon 7 (Groves et al., 1992) and 9 (Haber et al.,
1991) also indicated that all the members of family M were
homozygous at these sites (data not shown). An SSCP-PCR
sequencing analysis of the individual exons of WTJ in these
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patients was therefore carried out as described previously
(Baird et al., 1992a; Cowell et al., 1993). Despite complete
sequencing of the zinc finger region, no mutations were
detected. During SSCP analysis of the remaining six exons of
WTI in family M, an abnormal banding pattern was seen in
exon 1. PCR sequence analysis revealed that the band migra-
tion shift detected on the SSCP gel in this exon was due to a
sequence change resulting from a C-*T transition (Figure 4)
at position 390 according to the sequence described by Haber
et al. (1991). All three affected members of the family were
heterozygous at this position, whereas the unaffected father
(GOS 571) was homozygous for the C nucleotide (Figure 4).
This polymorphism occurs in the triplet sequence AAC,
which codes for asparagine, located at codon 130 in WTI,
and does not lead to any alteration of the amino acid
sequence. Coincidentally, this transition affects the recogni-
tion site (CGCG) of the restriction enzyme AccII, which
provides a convenient way of identifying this polymorphism.
The PCR product generated from the primer combination
WTlA/3XlB (Baird et al., 1992a) is 204 bp long and is not
A T C G A T C G A T C GA Tc GA T C GA T C
Blood -. Tumour Blood
ssv GOS 250 .-.O %N GOS 416
% -%
5,
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Figure 4 Sequence analysis of the AccII polymorphism in family M. The presence of a C or a T nucleotide at position 390 of the
WTJ gene appears in both constitutional (blood) and tumour DNA from the three affected individuals but not the unaffected
father.
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Figure 5 AccII analysis of the C/T polymorphism in family M.
A 204 bp PCR product was amplified using the primers WTClA/
3 x IB and digested with the restriction enzyme AccII to produce
two smaller fragments 128 bp and 76 bp long. One kilobase
marker ladders are shown in lanes 1 and 8. DNAs from affected
mother and unaffected father are shown in lanes 2 and 3 respec-
tively. DNAs from the tumours (T) from the two affected pro-
bands GOS 250 (lane 5) and GOS 416 (lane 6) are both
heterozygous and show they have both inherited the same WT
genes from their mother and father. DNA from blood (N) cells
from GOS 250 is shown in lane 4. Lane 7 contains DNA from a
Wilms tumour control (C) known to be C/C at this locus.
digested by AccII in T/T homozygotes (Figure 5). If the C
nucleotide is present, however, AccII digestion generates two
bands, 128 bp and 76 bp long (Figure 5). Analysis of family
M using the AccII restriction enzyme demonstrates that both
children have inherited the same allele from their affected
mother (Figure 5). Analysis of this polymorphism using
mRNA extracted from both blood and tumour samples
indicated that there was equal expression of both alleles (data
not shown).
Because of the suggestion that imprinting (see Discussion)
of the IGF-II gene at lp15 is relaxed in some WTs (Ogawa
et al., 1993; Rainer et al., 1993), we studied this locus in
family M. As both children in family M had inherited the
same maternal lip13 allele, but different maternal alleles at
1lpl5, we wanted to assess whether imprinting was a factor
in tumorigenesis in this family. A polymorphism in the 3'
untranslated region of the IGF-II gene was used to assess
mRNA expression. PCR products using the primers P2 and
P3 (Ogawa et al., 1993; Rainer et al., 1993) were used to
amplify a 292 bp product (Figure 6). The polymorphism
present in this fragment produces an ApaI enzyme digestion
site. Digestion with this enzyme produces two smaller
fragments, 231 bp and 61 bp long (Figure 6). Initially DNA
was amplified and digested to show that all family members
were heterozygous at this site (data not shown). In the
mRNA analysis, amplification might also result from con-
292 bp-->
taminating DNA. This potential problem was overcome by
pretreating the mRNA sample used for strand cDNA syn-
thesis with RNAse-free DNAse and checking that no PCR
products were produced (Figure 6). RNA expression in both
probands, as well as two controls, indicated that the 292 bp
allele was not expressed, whereas the allele with the ApaI site
was expressed in all cases (Figure 6).
LOH studies have indicated the site of a third possible WT
locus on the long arm of chromosome 16 (Maw et al., 1992).
To assess LOH of this chromosomal region of family M, two
CA repeats from the D16S289 (16q22-q23.l) (Shen et al.,
1992) and D16S305 (16q24.2-q24.3) (Thompson et al., 1992)
loci were studied. Each parent (GOS 570 and GOS 571) had
a unique number of CA repeats, distinguishable on polyac-
rylamide-urea gels, and analysis of the probands (GOS 250
and GOS 416) indicated normal Mendelian inheritance at
these loci with no evidence for LOH (data not shown).
Discussion
Fewer than 1% of all WT patients have a prior family
history of tumours (Beckwith, 1983; Bonaiti-Pellie et al.,
1992), and complete penetrance of WT, indicating autosomal
dominant inheritance, is unique. Mathematical consideration
of the age, incidence and frequency of bilateral tumours in
sporadic Wilms patients provided strong evidence for a
genetic basis for WT predisposition in some patients (Knud-
son & Strong, 1972). However, in previous studies of familial
WT involving only three kindreds no linkage to chromosome
11 markers was demonstrated and no evidence of a mutation
in WTI was found (Grundy et al., 1988; Huff et al., 1988;
Schwartz et al., 1991). In this study, although the family was
small, penetrance was complete, all tumours arose within the
first 8 months of life and each affected member had exactly
the same histological tumour subtype. Taken together, these
observations indicate that the disease phenotype is probably
due to an autosomal dominant mutation segregating in this
family which predisposes to tumorigenesis. Co-segregation of
markers from llpl3 with the tumour phenotype was
observed, but a recombination event between WTI and
HRAS demonstrates that the predisposition gene does not lie
in the llpl5 region in this family. Analysis of the AccII
polymorphism in exon 1 of WTI showed that both children
had inherited the same WTI gene from their affected mother.
It was possible, therefore, that a mutation in WTI was
responsible for tumour predisposition. However, tumour
DNA samples were heterozygous at the WTI locus. There
have been reports ofheterozygous mutations in WTI with no
associated loss of heterozygosity (Haber et al., 1990; Little et
al., 1992) but, although we sequenced the zinc finger regions
of the WTI gene, and performed an SSCP analysis of the
remaining exons, we could not detect any sequence abnor-
<=231bp
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Figure 6 PCR amplification of the part of the IGF-II mRNA containing the polymorphic Apal site allows the identification of
transcribed genes. Using primers P1 and P2, a 292 bp fragment is produced and, if the Apal site is intact, two bands are produced
on digestion, 231 and 61 bp long. Since the 61 bp fragment is small, it is difficult to visualise, but the presence of the 231 bp band is
sufficient to show that the ApaI site is present. In lanes 2-8 PCR products from the tumours from the affected children in family
M (GOS 249 and GOS 399) are shown together with control tumour samples (C). Lanes 2, 3 and 4 were from samples obtained in
the absence of reverse transcriptase and show negligible amplification; lanes 5-8 are from samples in the presence of reverse
transcriptase. When the samples from lanes 5-8 were digested with Apal all four showed the digested 231 bp allele. The weak
residual 292 bp band results in incomplete digestion, frequently seen in this type of experiment.1076 P.N. BAIRD et al.
malities, except for that responsible for the AccII polymor-
phism. In light of our past experience with SSCP/sequencing
(Baird et al., 1992b; Cowell et al., 1993), as well as that of
others (Coppes et al., 1993), we feel certain that mutations
are unlikely to be present within exons 1-6 of the coding
region of the WTI gene from the members of family M,
although we do accept that this technology may not be able
to detect all mutations. In addition, mRNA expression
studies, based on the AccII polymorphism, indicated that
both alleles were equally expressed in patients GOS 250 and
GOS 416, thereby arguing against a mutation in the pro-
moter region of WTI.
A number of studies, however, have indicated that
uniparental disomy for region llpl5 occurs in patients with
BWS and may be associated with the increased incidence of
WT observed in these patients (Henry et al., 1991). Our
analysis of the Ip15 region in family M, based on the ApaI
polymorphism in the IGF-II gene, indicated that the affected
probands were heterozygous, which excludes uniparental
disomy as a mechanism of tumorigenesis in this family. Two
loci (IGF-II and H19) in the 1lplS region are syntenic to loci
on mouse chromosome 7, and it has been shown that the
H19 locus is paternally imprinted (Bartolomei et al., 1991),
whereas the IGF-II locus is maternally imprinted (DeChiara
et al., 1991). Two recent reports indicate that both the H19
and IGF-II genes are also imprinted in normal human tissues
but that this imprinting is relaxed in WT (Ogawa et al., 1993;
Rainer et al., 1993). The ApaI polymorphism in the IGF-II
gene provides a convenient way of assessing which allele is
expressed in WT. In the tumours of the two probands of
family M there was no evidence for relaxation of imprinting
at this locus, as only one allele was expressed. It was not
possible to assess the parental origin of this allele as both
parents were heterozygous at this locus.
On the basis of relatively frequent LOH, it has been sug-
gested that a potential third WT locus lies within
chromosome region 16q22.1-16qter (Maw et al., 1992).
Using two CA repeats, D16S289 and D16S305, located in
16q22.2-q23.1 and 16q24.2-q24.3 respectively, no LOH was
detected in either of the tumours from the probands in family
M, indicating that these regions of chromosome 16 are
unlikely to contain a tumour-suppressor gene involved in
familial WT. This was also the conclusion of a recent linkage
analysis using five WT families (Huff et al., 1992).
In summary, all three tumours from family M had the
same monomorphous, epithelial-type WT, and all presented
at <1 year of age. This histological variant of WT accounts
for fewer than 5% of all Wilms tumours, so the chance of
this happening by coincidence within this family is less than
1:105. A specific genetic event, so far not defined, appears to
have been transmitted through the affected family members
which is causative of this particular histopathological change
but its chromosomal location is, as yet, unknown. Because of
the complete penetrance of the tumour phenotype this family
will clearly be important for the future characterisation of
candidate WT genes.
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